Hims & Hers Health (HIMS) Income from Continuing Operations (2019 - 2026)

Hims & Hers Health's (HIMS) quarterly Income from Continuing Operations came in at 92115000.0 in Q1 2026, down 286.15% year-on-year from 49485000.0 in Q1 2025, and down 547.14% quarter-over-quarter from 20601000.0 in Q4 2025.

Hims & Hers Health (HIMS) Income from Continuing Operations (2019 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Income from Continuing Operations across 8 years of filings, most recently posting 92115000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 92115000.0, down 286.15% year-over-year; the trailing twelve-month figure through Mar 2026 was 13235000.0 (down 108.05% YoY), and the FY2025 annual result was 128365000.0, up 1.85% from the prior year.
  • Income from Continuing Operations came in at 92115000.0 for Q1 2026 at Hims & Hers Health, down from 20601000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 75588000.0 in Q3 2024 to a low of 92115000.0 in Q1 2026.
  • The 5-year median for Income from Continuing Operations is 1245000.0 (2023), against an average of 4297882.35.
  • Across the five-year window, Income from Continuing Operations soared 1990.36% in 2024 and plunged 286.15% in 2026, its largest moves.
  • Hims & Hers Health's Income from Continuing Operations stood at 10907000.0 in 2022, then soared by 111.41% to 1245000.0 in 2023, then jumped by 1990.36% to 26025000.0 in 2024, then declined by 20.84% to 20601000.0 in 2025, then sank by 547.14% to 92115000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 92115000.0 (Q1 2026), 20601000.0 (Q4 2025), and 15774000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 52.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -92.12 Mn
Dec 31, 2025 20.60 Mn
Sep 30, 2025 15.77 Mn
Jun 30, 2025 42.51 Mn
Mar 31, 2025 49.49 Mn
Dec 31, 2024 26.03 Mn
Sep 30, 2024 75.59 Mn
Jun 30, 2024 13.30 Mn
Mar 31, 2024 11.13 Mn
Dec 31, 2023 1.25 Mn
Sep 30, 2023 -7.57 Mn
Jun 30, 2023 -7.16 Mn
Mar 31, 2023 -10.07 Mn
Dec 31, 2022 -10.91 Mn
Sep 30, 2022 -18.84 Mn
Jun 30, 2022 -19.68 Mn
Mar 31, 2022 -16.25 Mn
Dec 31, 2021 -31.16 Mn
Sep 30, 2021 -15.94 Mn
Jun 30, 2021 -9.15 Mn